Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Bulk Flupirtine Maleate CAS 75507-68-5 for Pharmaceutical Use and Research Purposes

Nov . 30, 2024 07:24 Back to list

Bulk Flupirtine Maleate CAS 75507-68-5 for Pharmaceutical Use and Research Purposes



Exploring Flupirtine Maleate A Comprehensive Overview


Flupirtine maleate (CAS 75507-68-5) is an intriguing pharmaceutical compound that has garnered attention in the realm of pain management and neuroprotection. This medication, a selective neuronal potassium channel opener, was first introduced in the mid-1980s and has since been recognized for its unique properties, differentiating it from traditional analgesics.


Mechanism of Action


Flupirtine operates through a dual mechanism. Primarily, it functions as a potassium channel opener, which leads to hyperpolarization of the neuron, thereby stabilizing the membrane potential and reducing excitability. This action results in analgesic effects without the side effects commonly associated with opioids, such as dependence and respiratory depression. Additionally, flupirtine exhibits NMDA receptor antagonism, which plays a crucial role in modulating the transmission of nociceptive (pain) signals, further establishing its effectiveness in pain relief.


Therapeutic Applications


Flupirtine maleate is predominantly prescribed for the treatment of acute and chronic pain. It has been effective in managing conditions such as neuropathic pain, fibromyalgia, and postoperative pain. Its role extends beyond pain relief; due to its neuroprotective properties, flupirtine has been researched for potential benefits in conditions such as multiple sclerosis and Alzheimer’s disease. The compound’s ability to inhibit excitotoxicity, a phenomenon where neurons are damaged due to excessive stimulation, presents a promising avenue for further research in neurodegenerative disorders.


Advantages Over Traditional Analgesics


wholesale flupirtine maleate cas 75507-68-5

wholesale flupirtine maleate cas 75507-68-5

One of flupirtine's most significant advantages is its favorable side effect profile compared to traditional analgesics like opioids and non-steroidal anti-inflammatory drugs (NSAIDs). Patients using flupirtine have reported lower incidences of gastrointestinal issues, sedation, and dependence. Moreover, its unique action mechanism allows for effective pain management without the high addiction potential seen in opioid medications, making it an appealing option for clinicians and patients alike.


Dosage and Administration


Flupirtine maleate is typically available in oral forms, including tablets and suspensions, with dosing tailored to the individual patient's needs. The standard dosage ranges from 100 mg to 400 mg per day, administered in divided doses. However, it is crucial for patients to follow their healthcare provider's instructions to mitigate any potential side effects, such as dizziness or somnolence, especially during the initiation of therapy.


Regulatory Status and Availability


While flupirtine has been approved for medical use in certain countries, its availability can vary widely. In Europe, it was once widely prescribed, but recent evaluations have led to restricted access in some regions due to concerns about liver toxicity associated with prolonged use. Consequently, it remains essential for healthcare providers to weigh the benefits against potential risks and to monitor liver function in patients receiving flupirtine therapy.


Conclusion


In conclusion, flupirtine maleate stands out as a unique therapeutic option in the landscape of analgesics and neuroprotectants. Its distinct mechanism of action offers an alternative pathway for pain management, particularly for patients who are intolerant to traditional therapies. As further research continues to unveil its potential applications and refine its safety profile, flupirtine may establish itself as a pivotal player in the management of various pain syndromes and as a promising candidate in neuroprotective therapies. However, careful consideration of its use remains paramount, ensuring patient safety and optimal therapeutic outcomes.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish